These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7018852)

  • 1. Antibacterial activity of Ro 13-9904 and preliminary experience in gonorrhoea and chronic urinary tract infections.
    Giamarellou H; Poulopoulos B; Katsabas A; Petrikkos G; Papapetropoulou M; Daikos GK
    Chemotherapy; 1981; 27 Suppl 1():70-4. PubMed ID: 7018852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin. A dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.
    Eichmann A; Weidmann G; Havas L
    Chemotherapy; 1981; 27 Suppl 1():62-9. PubMed ID: 6788458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and bacteriological results in urinary tract infections with single-dose Ro 13-9904 (Rocephin).
    Seiler W; Stähelin HB; Böhni E
    Chemotherapy; 1981; 27 Suppl 1():80-92. PubMed ID: 7018854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and in vitro evaluation of cephalexin. A new orally administered cephalosporin antibiotic.
    Levison ME; Johnson WD; Thornhill TS; Kaye D
    JAMA; 1969 Sep; 209(9):1331-6. PubMed ID: 4895869
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and laboratory evaluation of cephalexin in urinary-tract infections.
    Acar JF; Baudens JG; Chabbert YA
    Antimicrob Agents Chemother (Bethesda); 1969; 9():398-404. PubMed ID: 4919001
    [No Abstract]   [Full Text] [Related]  

  • 6. Cephaloglycin. Clinical and laboratory experience with an orally administered cephalosporin.
    Johnson WD; Applestein JM; Kaye D
    JAMA; 1968 Dec; 206(12):2698-702. PubMed ID: 4386947
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of urinary tract infections with cephalexin an oral antibiotic of cephalosporin-group].
    Hofmeister H; Scharrer G; Sawallisch R
    Arzneimittelforschung; 1970 Jan; 20(1):139-42. PubMed ID: 4986282
    [No Abstract]   [Full Text] [Related]  

  • 8. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cephacetrile--a new cephalosporin antibiotic.
    Hodson AH; Holloway WJ
    Int J Clin Pharmacol; 1973 Feb; 7(1):89-94. PubMed ID: 4699390
    [No Abstract]   [Full Text] [Related]  

  • 10. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2002 Feb; 55(1):22-60. PubMed ID: 11977920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cephalothin: antibacterial activity in vitro and treatment of infections in man.
    Altucci P; Sapio U; Varone GL
    Chemotherapy; 1967; 12(2):89-100. PubMed ID: 4383219
    [No Abstract]   [Full Text] [Related]  

  • 12. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
    Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
    Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of New Delhi metallo-β-lactamase 1 (NDM-1) producing and multidrug resistant uropathogens causing urinary tract infections in Andaman Islands, India.
    Bhattacharya D; Thamizhmani R; Bhattacharya H; Sayi DS; Muruganandam N; Roy S; Sugunan AP
    Microb Drug Resist; 2013 Dec; 19(6):457-62. PubMed ID: 23862639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitivity to some antibacterial agents, of the microbial flora isolated from patients with infections of the urinary tract in the years 1964-1967].
    Diana L; Romano M; Perin G
    Ig Mod; 1968; 61(5):292-315. PubMed ID: 4889607
    [No Abstract]   [Full Text] [Related]  

  • 15. Laboratory and clinical studies of a new antibiotic, cephaloglycin in the treatment of urinary tract infections.
    Boyer JL; Andriole VT
    Yale J Biol Med; 1968 Feb; 40(4):284-95. PubMed ID: 4870320
    [No Abstract]   [Full Text] [Related]  

  • 16. [Laboratory and clinical evaluation of Cefazolin].
    Kiriyama T; Takara M; Hayashida S; Sakatoku J
    Hinyokika Kiyo; 1971 Dec; 17(12):775-80. PubMed ID: 5004290
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental evaluation of the new cephalosporin antibiotic cephacetrile].
    Kradolfer F; Ahrens T; Gelzer J; Vischer W; Zimmermann W
    Arzneimittelforschung; 1974 Sep; 24(9b):1446-51. PubMed ID: 4154769
    [No Abstract]   [Full Text] [Related]  

  • 18. Cephalexin monohydrate in the treatment of urinary tract infections and urethritis.
    Rocha H; Peltier Queiroz F
    Prensa Med Mex; 1970; ():56-60. PubMed ID: 4931118
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of gentamicin and other therapeutic drugs on the causative agents in urinary tract infections. 10-year report].
    Schmid W
    Med Welt; 1980 Jan; 31(1):32-6. PubMed ID: 6770223
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of urinary tract infections with cephalexin.
    Möhring K; Genster HG; Madsen PO
    J Urol; 1971 Nov; 106(5):757-60. PubMed ID: 4940185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.